Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Operating Expenses: 2020-2025

Historic Operating Expenses for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $307.8 million.

  • Roivant Sciences' Operating Expenses fell 11.09% to $307.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 19.95%. This contributed to the annual value of $1.1 billion for FY2025, which is 29.26% up from last year.
  • Latest data reveals that Roivant Sciences reported Operating Expenses of $307.8 million as of Q3 2025, which was up 7.21% from $287.1 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Operating Expenses peaked at $698.4 million during Q3 2021, and registered a low of $162.1 million during Q2 2021.
  • Its 3-year average for Operating Expenses is $274.6 million, with a median of $285.2 million in 2024.
  • Its Operating Expenses has fluctuated over the past 5 years, first spiked by 342.42% in 2021, then slumped by 58.01% in 2022.
  • Over the past 5 years, Roivant Sciences' Operating Expenses (Quarterly) stood at $270.4 million in 2021, then soared by 46.15% to $395.1 million in 2022, then plummeted by 40.14% to $236.5 million in 2023, then increased by 19.82% to $283.4 million in 2024, then dropped by 11.09% to $307.8 million in 2025.
  • Its Operating Expenses stands at $307.8 million for Q3 2025, versus $287.1 million for Q2 2025 and $283.4 million for Q4 2024.